Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$9.82M |
| 2 |
Dollar Tree
DLTR
|
+$8.78M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$7.72M |
| 4 |
Elevance Health
ELV
|
+$7.55M |
| 5 |
Cigna
CI
|
+$7.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FDC
First Data Corporation
FDC
|
+$14.8M |
| 2 |
AET
Aetna Inc
AET
|
+$12.6M |
| 3 |
Merck
MRK
|
+$12.6M |
| 4 |
BRSL
Brightstar Lottery PLC
BRSL
|
+$12.6M |
| 5 |
Northrop Grumman
NOC
|
+$12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.17% |
| 2 | Consumer Discretionary | 17.86% |
| 3 | Industrials | 12.79% |
| 4 | Financials | 9.03% |
| 5 | Technology | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
United Airlines
UAL
$36.7B
| $1.17M | 0.1% |
17,377
-88,728
| -84% | -$5.53M |
|
277
Bio-Rad Laboratories Class A
BIO
$10.2B
| $1.16M | 0.1% |
+4,864
| New | +$1.18M |
|
278
Brown & Brown
BRO
$24.4B
| $1.16M | 0.09% |
+45,024
| New | +$1.13M |
|
279
Prosperity Bancshares
PB
$8.75B
| $1.16M | 0.09% |
16,534
-3,593
| -18% | -$240K |
|
280
Applied Industrial Technologies
AIT
$12.5B
| $1.15M | 0.09% |
+16,916
| New | +$1.08M |
|
281
UDR
UDR
$12.1B
| $1.14M | 0.09% |
+29,719
| New | +$1.16M |
|
282
Abercrombie & Fitch
ANF
$4.84B
| $1.14M | 0.09% |
+65,453
| New | +$994K |
|
283
Knowles
KN
$2.85B
| $1.13M | 0.09% |
76,921
-11,290
| -13% | -$176K |
|
284
Vulcan Materials
VMC
$35.8B
| $1.13M | 0.09% |
8,772
+428
| +5% | +$52.3K |
|
285
ResMed
RMD
$33.4B
| $1.12M | 0.09% |
+13,253
| New | +$1.09M |
|
286
Micron Technology
MU
$1.09T
| $1.11M | 0.09% |
+26,887
| New | +$1.16M |
|
|
OPLN
287
Openlane
OPLN
$4.08B
| $1.1M | 0.09% |
57,767
+26,422
| +84% | +$489K |
|
288
SiriusXM
SIRI
$9.67B
| $1.1M | 0.09% |
20,496
+18,895
| +1,180% | +$1.04M |
|
289
Texas Capital Bancshares
TCBI
$4.27B
| $1.1M | 0.09% |
12,363
+2,598
| +27% | +$225K |
|
290
American Express
AXP
$227B
| $1.1M | 0.09% |
11,047
+6,827
| +162% | +$650K |
|
291
T. Rowe Price
TROW
$23.8B
| $1.1M | 0.09% |
+10,458
| New | +$1.02M |
|
292
Innoviva
INVA
$1.52B
| $1.09M | 0.09% |
76,780
-30,235
| -28% | -$403K |
|
|
BKI
293
DELISTED
Black Knight, Inc. Common Stock
BKI
| $1.09M | 0.09% |
+24,691
| New | +$1.12M |
|
294
Xenon Pharmaceuticals
XENE
$5.88B
| $1.09M | 0.09% |
385,000
+110,000
| +40% | +$299K |
|
|
EQC
295
DELISTED
Equity Commonwealth
EQC
| $1.08M | 0.09% |
35,478
+13,928
| +65% | +$422K |
|
296
Advanced Energy
AEIS
$11.4B
| $1.08M | 0.09% |
16,001
+12,611
| +372% | +$1.02M |
|
297
Sanofi
SNY
$110B
| $1.08M | 0.09% |
+25,061
| New | +$1.16M |
|
298
UGI
UGI
$8.06B
| $1.07M | 0.09% |
+22,814
| New | +$1.09M |
|
|
CXP
299
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $1.06M | 0.09% |
46,171
-194
| -0.4% | -$4.3K |
|
|
LJPC
300
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $1.05M | 0.09% |
+32,703
| New | +$1.07M |
|
Similar funds
Steve Schonfeld's Q4 2017 Portfolio in Review
As of Q4 2017, Steve Schonfeld held 998 positions worth $1.22B, up 12% from $1.1B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Steve Schonfeld deployed $160M of net new capital in Q4 2017, opening 433 new positions and adding to 145 existing holdings. Its largest new stake was State Street SPDR S&P MIDCAP 400 ETF Trust: 29,148 shares worth $10.1M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Aetna Inc, an estimated $12.6M trimmed.
- Steve Schonfeld's largest Q4 2017 buy was State Street SPDR S&P MIDCAP 400 ETF Trust: 29,148 shares worth $10.1M.
- Steve Schonfeld added most to Dollar Tree in Q4 2017, an estimated $8.78M increase.
- Steve Schonfeld's biggest Q4 2017 reduction was Aetna Inc, cutting an estimated $12.6M.
- Steve Schonfeld fully exited First Data Corporation in Q4 2017, selling an estimated $14.8M.
- Steve Schonfeld's ten largest holdings make up 9.3% of its $1.22B portfolio in Q4 2017.
- Steve Schonfeld opened 433 new positions and closed 273 in Q4 2017.
- Steve Schonfeld's portfolio value rose 12% quarter-over-quarter to $1.22B.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.